Quick Answer
Tonix Pharmaceuticals Holding Corp. reported Total Assets of $277.17 million for fiscal year 2025.
Tonix Pharmaceuticals Holding Corp. Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $277.17M | +70.2% |
| 2024 | $162.89M | +5.5% |
| 2023 | $154.46M | -31.6% |
| 2022 | $225.69M | -6.3% |
| 2021 | $240.90M | +145.4% |
| 2020 | $98.18M | +574.4% |
| 2019 | $14.56M | -44.7% |
| 2018 | $26.32M | -1.6% |
| 2017 | $26.75M | -2.7% |
| 2016 | $27.51M | -41.5% |
| 2015 | $47.02M | +18.9% |
| 2014 | $39.54M | +352.6% |
| 2013 | $8.74M | +312.7% |
| 2012 | $2.12M | +397.6% |
| 2011 | $425.4K | +131.2% |
| 2010 | $184.0K | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $252.44M | +165.8% | +34.7% |
| June 30, 2025 | $187.36M | +166.5% | -2.9% |
| March 31, 2025 | $192.87M | +42.5% | +18.4% |
| December 31, 2024 | $162.89M | +5.5% | +71.5% |
| September 30, 2024 | $94.99M | -31.8% | +35.1% |
| June 30, 2024 | $70.31M | -56.0% | -48.1% |
| March 31, 2024 | $135.34M | -24.4% | -12.4% |
| December 31, 2023 | $154.46M | -31.6% | +10.9% |
- Tonix Pharmaceuticals Holding Corp. showed an increase of +70.2% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, Tonix Pharmaceuticals Holding Corp.’s total assets has grown by 150535.6% (from $184.0 thousand to $277.17 million).
- The most recent figure is from Tonix Pharmaceuticals Holding Corp.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: